The novel GENOLINK™ solution expands the PROTEINEER suite into an integrated analytical platform for functional genomics. The linked platform supports combined genetics, gene expression and proteomics approaches and thus opens powerful new ways of discovering disease markers and drug targets.
MALDI-TOF MS serves as the core analytical technology, meeting the demands of both SNP genotyping and proteomics tasks.